• Keine Ergebnisse gefunden

The Evolution of Intensive Care Medicine

N/A
N/A
Protected

Academic year: 2022

Aktie "The Evolution of Intensive Care Medicine"

Copied!
3
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

5

Contents

Welcome Addresses and Greetings

Ganten, Detlev: Welcome (Chairman, Scientific Commission on Health at the Leo- poldina) ... 11 Spies, Claudia: Welcome (Chair of the Symposium) ... 13 Kesecioglu, Jozef: Welcome Address (President-Elect, European Society of Intensive

Care Medicine) ... 15 Schwab, Stefan, and Waydhas, Christian: Greeting (President and Speaker, German In-

terdisciplinary Association for Intensive Care and Emergency Medicine [DIVI]) ... 17 Zwissler, Bernhard: Greeting (President, German Society of Anesthesiology and In-

tensive Care Medicine [DGAI]) ... 19 Ullrich, Lothar: Greeting (First Chairman, German Society of Specialist Nursing and

Functional Services [DGF]) ... 21 Jonitz, Günther: Greeting (President, Berlin Chamber of Physicians) ... 23 Czaja, Mario: Greeting (Former Senator for Health and Social Affairs) ... 25 Current Perspectives and Future Innovations in Intensive Care Medicine

Lachmann, Gunnar, Weiss, Björn, Mörgeli, Rudolf, Wolf, Alissa, and Spies, Clau- dia: The Evolution of Intensive Care Medicine: From Recumbency to Fully Func- tioning in Every Day Life ... 29 Niehaus, Jochen, and Ganten, Detlev: Health and Critical Illness from a Global Per-

spective ... 33 Denke, Claudia: Surviving Critical Illness: A Patient’s Interview ... 39 Intensive Care 2017: A High Price for Everyone

Brummel, Nathan: After Struggling with Death: What Price Does the Patient Pay for Survival? ... 47 Wunsch, Hannah: What is PICS from a Public Health Point of View? ... 49 Müller-Werdan, Ursula: Regaining Strength after the ICU ... 51 Flaatten, Hans: Multisystem Organ Failure: Why Doctors Look at the Wrong Organs ... 53

(2)

6

Innovations and Basic Conditions

Kesecioglu, Jozef: What’s the Personal Price for Innovation? Looking Back on 10

Years of Enforcing and Managing a New ICU Concept ... 61

Busse, Reinhard: An Economic Analysis of Intensive Care and the Time After Survival: It May Not Be Cost-Effective to Save at the Wrong End ... 65

Willemeit, Thomas: Designing a Healing Environment: What’s Personal and Public Investment ... 69

Chiche, Jean-Daniel: Life-Priority ... 75

Sleep Function and Dysfunction Luetz, Alawi: Prevention of Delirium by a Modification in ICU Environment ... 81

Pisani, Margaret: Delirium and Circadian Integrity ... 85

Hatta, Kotaro: Melatonin: Panacea or Futile Hope? ... 91

Shehabi, Yahya: Evidence Gap to the Ideal Patient-Centered Care ... 95

Reduction of Stress Weber-Carstens, Steffen: Glucose Utilization and Critical Illness ... 103

Slooter, Arjen: EEG-Based Diagnostics of Delirium ... 107

Zeilhofer, Hanns Ulrich: GABAA Receptors: The Forgotten Target ... 109

Hart, Nicholas: Reducing Stress, Increasing Strength: Early Mobilization and Impact on Long-Term Outcome ... 115

Surviving the Intensive Care Unit Winterer, Georg: Surgery Successful – But Patient Demented ... 123

Sander, Michael: Perioperative Optimization and Postoperative Outcomes: From Al- pha to Omega ... 127

Gerrard, Nicci: How to Improve Things: A Relative’s Perspective ... 133

Innovations in Intensive Care Medicine, Perspectives from the Industry Raspé, Christoph: Patient-Centered Innovation in Intensive Care Medicine – Hemody- namic Monitoring (Edwards Lifesciences Services GmbH) ... 137

Falck, Thomas, Eerden, Jacco, and Meekes, Gaby: Patient-Centered Innovations for Intensive Care Medicine (Philips Healthcare) ... 143

König, Alexander: Towards a Connected Intensive Care Unit (ReActive Robotics GmbH) ... 149

(3)

7 Zivkovic, Aleksandar R., Schmidt, Karsten, and Hofer, Stefan: Point-of-Care Test-

ing of the Serum Cholinesterase Activity. A Novel Early Indicator of the Systemic Inflammation or Yet Another Vague Sepsis Biomarker? (Dr. F. Köhler Chemie GmbH) ... 151 Scheier, Jörg: CytoSorb® to Counteract Excessive Hyperinflammation in Intensive

Care Unit Patients (CytoSorbents Europe GmbH) ... 157 Strategies to Achieve Patient-Centered-Outcomes

Spies, Claudia, Lachmann, Gunnar, and Schäfer, Michael: Gaps and Evidence ... 163 Scientific Symposium Abstract Winner

Keller, Johannes, Jeschke, Anke, Schinke, Thorsten, and Amling, Michael: 1st Prize: Protection from Septic Shock in Mice with Genetic Inactivation of Procal- citonin ... 171 Grunow, Julius, Wollersheim, Tobias, Kny, Melanie, Carbon, Niklas M., Giesecke,

Moritz, Birchmeier, Carmen, Fielitz, Jens, and Weber-Carstens, Steffen: 2nd Prize: Protocol Based Physiotherapy and Muscle Activating Measures Improve Skeletal Muscle Synthesis in Intensive Care Unit acquired Weakness ... 173 Zanders, Lukas, Kny, Melanie, McShane, Erik, Lahmann, Ines, Selbach, Matthias,

Birchmeier, Carmen, and Fielitz, Jens: 3rd Prize: Muscular Glycoprotein 130 Mediates Inflammation-Induced Muscle Atrophy in Mice ... 177

Referenzen

ÄHNLICHE DOKUMENTE

In conclusion, I demonstrated CHC22 to be required for endosomal sorting of various cargoes in epithelial and skeletal muscle cells and for generation of the specialized

Figure 1: Sustained activation of mTORC1 does increase oxidative capacity of skeletal muscle in young mice, without changing mitochondrial number and dynamics.. (A) Enzymatic SDH

Mutations in the gene encoding this channel have been associated with a number of debilitating or life-threatening neuromuscular pathologies including malignant

AMP-activated protein kinase (AMPK) is another kinase known to phosphorylate PGC-1α and thereby increase PGC-1α activity and transcriptional induction of mitochondrial

Therefore, even though endurance and resistance training induce divergent effects on skeletal muscle remodelling, it appears that adaptations to both of these types of

APPENDIX Publication 3 (Bentzinger et al. 2008): Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy

A project oriented towards a similar goal was conceived and published by Zechner et al recently 150 : Ablation of both PGC-1 isoforms compared to the absence/

Thus, the low levels of raptor and rictor protein that were detected in the RAmKO and RImKO muscles are ascribable to the expression of raptor or rictor in non-targeted cells, such